| Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller The Lancet infectious diseases 15 (5), 535-543, 2015 | 462 | 2015 |
| Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller The Lancet infectious diseases 15 (5), 535-543, 2015 | 461 | 2015 |
| Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome S Ladhani, CL Joannou, DP Lochrie, RW Evans, SM Poston Clinical microbiology reviews 12 (2), 224-242, 1999 | 386 | 1999 |
| Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study NJ Andrews, PA Waight, P Burbidge, E Pearce, L Roalfe, M Zancolli, ... The Lancet infectious diseases 14 (9), 839-846, 2014 | 334 | 2014 |
| The changing and dynamic epidemiology of meningococcal disease SA Halperin, JA Bettinger, B Greenwood, LH Harrison, J Jelfs, ... Vaccine 30, B26-B36, 2012 | 334 | 2012 |
| Presentation of vitamin D deficiency S Ladhani, L Srinivasan, C Buchanan, J Allgrove Archives of disease in childhood 89 (8), 781-784, 2004 | 286 | 2004 |
| Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome S Ladhani, B Lowe, AO Cole, K Kowuondo, CRJC Newton British journal of haematology 119 (3), 839-847, 2002 | 281 | 2002 |
| Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards … JM Davies, MPN Lewis, J Wimperis, I Rafi, S Ladhani, PHB Bolton‐Maggs British journal of haematology 155 (3), 308-317, 2011 | 266 | 2011 |
| Non-typeable Haemophilus influenzae, an under-recognised pathogen J Van Eldere, MPE Slack, S Ladhani, AW Cripps The Lancet infectious diseases 14 (12), 1281-1292, 2014 | 233 | 2014 |
| Non-typeable Haemophilus influenzae, an under-recognised pathogen J Van Eldere, MPE Slack, S Ladhani, AW Cripps The Lancet infectious diseases 14 (12), 1281-1292, 2014 | 233 | 2014 |
| Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study SN Ladhani, S Collins, A Djennad, CL Sheppard, R Borrow, NK Fry, ... The Lancet Infectious Diseases 18 (4), 441-451, 2018 | 225 | 2018 |
| Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study SR Parikh, NJ Andrews, K Beebeejaun, H Campbell, S Ribeiro, C Ward, ... The Lancet 388 (10061), 2775-2782, 2016 | 219 | 2016 |
| Invasive Haemophilus influenzae disease, Europe, 1996–2006 S Ladhani, MPE Slack, PT Heath, A Von Gottberg, M Chandra, ... Emerging infectious diseases 16 (3), 455, 2010 | 210 | 2010 |
| Increasing antibiotic resistance among urinary tract isolates S Ladhani, W Gransden Archives of disease in childhood 88 (5), 444-445, 2003 | 188 | 2003 |
| Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales SN Ladhani, K Beebeejaun, J Lucidarme, H Campbell, S Gray, ... Clinical Infectious Diseases 60 (4), 578-585, 2015 | 183 | 2015 |
| Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label … CS Waddington, WT Walker, C Oeser, A Reiner, T John, S Wilkins, ... Bmj 340, 2010 | 174 | 2010 |
| Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England AJ van Hoek, CL Sheppard, NJ Andrews, PA Waight, MPE Slack, ... Vaccine 32 (34), 4349-4355, 2014 | 170 | 2014 |
| Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus S Ladhani FEMS Immunology & Medical Microbiology 39 (2), 181-189, 2003 | 150 | 2003 |
| Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines SN Ladhani, JS Flood, ME Ramsay, H Campbell, SJ Gray, EB Kaczmarski, ... Vaccine 30 (24), 3710-3716, 2012 | 130 | 2012 |
| Incidence, etiology, and outcome of bacterial meningitis in infants aged< 90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population … IO Okike, AP Johnson, KL Henderson, RM Blackburn, B Muller-Pebody, ... Clinical infectious diseases 59 (10), e150-e157, 2014 | 125 | 2014 |
